Profiles in Business - December 8, 2025
Leif Johansson: “We should double the government’s R&D funding from 1% to 2% of GDP”
Successful businessman and former chairman of AstraZeneca, Leif Johansson, has accumulated vast experience and knowledge about international competition, leadership, business development, and entrepreneurship, not least when it comes to science-driven industries like the life science industry.
Profiles in Business - November 12, 2025
Anders Tuv: Connecting the dots & Driving progress
Anders Tuv’s varied background as an investor, founder, and company builder has taken him to the very center of the multidisciplinary nature of creating a life science company. As Managing Director at Radforsk Invest he truly enjoys shaping strategies and helping startups implement and realize innovations.
Profiles in Business - November 11, 2025
Sam Sihvonen: Preventing the next pandemic
When Sam Sihvonen, co-founder and CEO of Solu, sees a problem, he wants to fix it.
Profiles in Business - November 9, 2025
Kristofer Klerfalk: Building stamina to walk the startup miles
Life science entrepreneur, investor, and baritone tenor Kristofer Klerfalk is a man with many hats and a vision for a pan-Nordic life science ecosystem.
Careers article - November 2, 2025
“Adaptability and originality are as important as expertise”
Imagine your job involves meeting with entrepreneurs and researchers who are passionate about developing drugs that could transform or save lives, and realizing you could be part of that future. That is just another “day at the office” for Ester Sklarsky, who has been a principal for the Swedish venture capital firm Sound Bioventures for the past three and a half years.
Careers article - June 13, 2025
“I love science, but I love investing in science even more”
Despite international turbulence and news of life sciences and research funding disruptions in the U.S., investment in innovative life sciences projects continues, according to Mala Valroy, an investment manager with Industrifonden, one of Sweden’s largest evergreen venture capital (VC) funds.